EHA 2023 Hybrid Congress

At EHA this year, we will share new data from our robust portfolio and pipeline of advanced therapeutic platforms in cancer and blood disorders, showcasing the impact of our bold science in research.

Bold Science: Transforming Lives, Striving for Cures
Reimagining Cancer and Blood Disorders

Novartis continues to pursue scientific breakthroughs with the ambition to transform lives and renew patients’ hopes for the future. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our medicines.